Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thaneswari Karpanasamy
Institutions:
Queen Mary University of London,
Barts Cancer Institute,
University College London
Observed institutions:
Queen Mary University of London,
Barts Cancer Institute,
University College London
ORCID:
0000-0002-5109-3695
Observed ORCID:
0000-0002-5109-3695
OpenAlex ID:
A5060608121
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
2022
·
Paul M. Maciocia
, Patrycja A. Wawrzyniecka
, et al.
·
Blood
·
72
PDF
Cancer evolution: from Darwin to the Extended Evolutionary Synthesis
2025
·
Thomas Savy
, Lucy Flanders
, et al.
·
Trends in cancer
·
16
Anti-CD21 Chimeric Antigen Receptor (CAR)-T Cells for T Cell Acute Lymphoblastic Leukaemia (T-ALL)
2021
·
Nicola C Maciocia
, Amy Burley
, et al.
·
Blood
·
8
A Novel Protein-Based Approach to Generate Allogeneic CAR-T Cells with Simultaneous TCR and MHC Class 1 Downregulation
2022
·
Thaneswari Karpanasamy
, Patrycja Wawrzyniecka
, et al.
·
Blood
·
2
Anti-CCR9 CAR-T Cells for T Acute Lymphoblastic Leukemia
2021
·
Paul M Maciocia
, Patrycja Wawrzyniecka
, et al.
·
Blood
·
2
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia
2025
·
Nicola Maciocia
, Malika Hoekx
, et al.
·
Science Translational Medicine
·
1
Pharmacological Modulation of CD21 Antigen Density Enhances Chimeric Antigen Receptor (CAR-T) Cell Function
2022
·
Nicola C Maciocia
, Amy Burley
, et al.
·
Blood
Show more works
View as search
Works count:
8
Citation count:
103
H-index:
3
I10-index:
2
Year
Topic
Type